9EHY | pdb_00009ehy

X-ray crystal structure of ADC-33 beta-lactamase in complex with ceftazidime in acyl and product forms


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.57 Å
  • R-Value Free: 
    0.220 (Depositor), 0.223 (DCC) 
  • R-Value Work: 
    0.192 (Depositor), 0.196 (DCC) 
  • R-Value Observed: 
    0.193 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter -derived cephalosporinase-33 (ADC-33), a class C beta-lactamase present in carbapenem-resistant Acinetobacter baumannii (CR Ab ).

Powers, R.A.Wallar, B.J.Jarvis, H.R.Ziegler, Z.X.June, C.M.Bethel, C.R.Hujer, A.M.Taracila, M.A.Rudin, S.D.Hujer, K.M.Prati, F.Caselli, E.Bonomo, R.A.

(2025) mBio 16: e0028725-e0028725

  • DOI: https://doi.org/10.1128/mbio.00287-25
  • Primary Citation of Related Structures:  
    9EHY

  • PubMed Abstract: 

    Antimicrobial resistance in Acinetobacter baumannii is partly mediated by chromosomal class C β-lactamases, the Acinetobacter -derived cephalosporinases (ADCs). Recently, a growing number of emerging variants were described, expanding this threat. Consistent with other β-lactamases, one of the main areas of variance exists in the Ω-loop region near the site of cephalosporin binding. Interestingly, a common alanine duplication (Adup) is found in this region. Herein, we studied specific Adup variants expressed in a uniform Escherichia coli genetic background that demonstrated high-level resistance to multiple oxyimino-cephalosporins. For ceftolozane and ceftazidime, the Adup ADCs significantly increased levels of resistance (minimum inhibitory concentration [MIC] ≥ 512 µg/mL and MIC ≥ 1,024 µg/mL, respectively). These observations were consistent with the increased k cat / K M for ceftazidime. For cefiderocol, three Adup variants exhibited increased MICs and increased k cat / K M for this compound. Timed electrospray ionization mass spectrometry demonstrated stable cephalosporin:ADC adducts with ADC-30 (non-Adup), but not with ADC-33 (Adup), consistent with turnover. The X-ray crystal structure of Adup variant ADC-33 in complex with ceftazidime was determined (1.57 Å resolution) and suggests that increased turnover is facilitated by conformational changes (shift in Tyr221 and orientation of the oxyimino portion of the R1 side chain) and repositioning of water in the active site. These changes appear to favor substrate-assisted catalysis as an alternative mechanism to base-assisted catalysis. These studies also provide unprecedented insight into the mechanism underlying oxyimino-cephalosporin hydrolysis by expanded-spectrum ADC β-lactamases and possibly other class C β-lactamases, which is of critical importance to future drug design.IMPORTANCEThe characterization of emerging Acinetobacter -derived cephalosporinase (ADC) variants is necessary to understand the increasing resistance to β-lactam antibiotics in Acinetobacter spp. In this study, cefiderocol retains effectiveness against ADC variants with and without an Ω-loop alanine duplication (Adup). However, the presence of the Adup appears to introduce loop flexibility and structural alterations resulting in increased resistance and steady-state turnover of larger cephalosporins. Further characterization provides unprecedented insight into the mechanism of cephalosporin hydrolysis by ADC β-lactamases and supports a concomitant increase in ADC structural flexibility and cephalosporin affinity that leads to more efficient hydrolysis. In addition, the crystal structure of ADC-33 in complex with ceftazidime is consistent with a substrate-assisted catalysis mechanism. The structural differences in the ADC-33 active site leading to ceftazidime catalysis provide a better understanding of β-lactamase Adup variants and open important opportunities for future drug design and development.


  • Organizational Affiliation
    • Department of Chemistry, Grand Valley State University, Allendale, Michigan, USA.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Beta-lactamaseA [auth B],
B [auth A]
362Acinetobacter baumanniiMutation(s): 0 
Gene Names: ampCBAA1790NC_1053EP550_05490EP560_12590EQH48_05445
EC: 3.5.2.6
UniProt
Find proteins for A7Y407 (Acinetobacter baumannii)
Explore A7Y407 
Go to UniProtKB:  A7Y407
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA7Y407
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1BIM (Subject of Investigation/LOI)
Query on A1BIM

Download Ideal Coordinates CCD File 
C [auth B],
E [auth A]
(2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}(carboxy)methyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
C17 H19 N5 O8 S2
LORMEESTXGATOD-DGLGDVFNSA-N
CAZ (Subject of Investigation/LOI)
Query on CAZ

Download Ideal Coordinates CCD File 
D [auth B]ACYLATED CEFTAZIDIME
C17 H19 N5 O7 S2
VEHPZKIFULQYFS-BZXVCXBKSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.57 Å
  • R-Value Free:  0.220 (Depositor), 0.223 (DCC) 
  • R-Value Work:  0.192 (Depositor), 0.196 (DCC) 
  • R-Value Observed: 0.193 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 43.127α = 90
b = 84.055β = 90
c = 205.597γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata scaling
PHASERphasing
autoPROCdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesR01AI072219

Revision History  (Full details and data files)

  • Version 1.0: 2025-05-14
    Type: Initial release
  • Version 1.1: 2025-05-28
    Changes: Database references
  • Version 1.2: 2025-06-25
    Changes: Database references
  • Version 1.3: 2025-07-23
    Changes: Database references